Compare · ECL vs UG
ECL vs UG
Side-by-side comparison of Ecolab Inc. (ECL) and United-Guardian Inc. (UG): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ECL and UG operate in Package Goods/Cosmetics (Consumer Discretionary), so they compete in similar markets.
- ECL is the larger of the two at $72.44B, about 2288.6x UG ($31.7M).
- Over the past year, ECL is down 3.4% and UG is down 16.9% - ECL leads by 13.6 points.
- ECL has hit the wire 20 times in the past 4 weeks while UG has been quiet.
- ECL has more recent analyst coverage (25 ratings vs 0 for UG).
- Company
- Ecolab Inc.
- United-Guardian Inc.
- Price
- $257.46-0.23%
- $6.96-1.97%
- Market cap
- $72.44B
- $31.7M
- 1M return
- +0.37%
- -1.56%
- 1Y return
- -3.39%
- -16.95%
- Industry
- Package Goods/Cosmetics
- Package Goods/Cosmetics
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 20
- 0
- Recent ratings
- 25
- 0
Ecolab Inc.
Ecolab Inc. provides water, hygiene, and infection prevention solutions and services worldwide. Its Global Industrial segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, metals and mining, power generation, pulp and paper, commercial laundry, petroleum, and petrochemical industries. The company's Global Institutional & Specialty segment provides specialized cleaning and sanitizing products to the foodservice, hospitality, lodging, government and education, and retail industries. Its Global Healthcare & Life Sciences segment offers specialized cleaning and sanitizing products to the healthcare, personal care, and pharmaceutical industries, such as infection prevention and surgical solutions, and end-to-end cleaning and contamination control solutions under the Ecolab, Microtek, and Anios brand names. The company's Other segment offers pest elimination services to detect, eliminate, and prevent pests, such as rodents and insects in restaurants, food and beverage processors, educational and healthcare facilities, hotels, quick service restaurant and grocery operations, and other institutional and commercial customers. This segment also provides colloidal silica for binding and polishing applications in semiconductor, catalyst, and aerospace component manufacturing, as well as chemical industries; and products and services that manage wash process through custom designed programs, premium products, dispensing equipment, water and energy management, and reduction, as well as real time data management. It sells its products through field sales and corporate account personnel, distributors, and dealers. The company was founded in 1923 and is headquartered in St. Paul, Minnesota.
United-Guardian Inc.
United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products in the United States and internationally. It offers cosmetic ingredients, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL NATURAL consisting of natural ingredients for cosmetic use; LUBRAJEL MARINE; LUBRASIL II SB, a special formulation of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base; LUBRAJEL II XD; B-122, a powdered lubricant that is used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; KLENSOFT, a surfactant, which is used in shampoos, shower gels, makeup removers, and other cosmetic formulations; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics. The company's medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC and LUBRAJEL FA that are LUBRAJEL formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. Its pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder, and localized infections in the peritoneum, as well as eye, ear, nose and throat, and sinuses. The company's industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. It also conducts research and development primarily related to the development of cosmetic ingredients. The company markets its products through marketing partners, distributors, and wholesalers. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.
Latest ECL
- Ecolab Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form SD filed by Ecolab Inc.
- Director Vautrinot Suzanne M exercised 2,000 shares at a strike of $125.67, covered exercise/tax liability with 996 shares and sold $266,040 worth of shares (1,004 units at $264.98) (SEC Form 4)
- Ecolab Schedules Webcast of Industry Conference for June 2, 2026
- Ecolab upgraded by UBS with a new price target
- SEC Form 424B5 filed by Ecolab Inc.
- SEC Form 4 filed by Director Zillmer John J
- SEC Form 4 filed by Director Whalen Julie
- SEC Form 4 filed by Director Vautrinot Suzanne M
- SEC Form FWP filed by Ecolab Inc.
Latest UG
- United-Guardian Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form 10-Q filed by United-Guardian Inc.
- United-Guardian Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- United-Guardian Reports First Quarter Results
- SEC Form DEF 14A filed by United-Guardian Inc.
- SEC Form 10-K filed by United-Guardian Inc.
- United-Guardian Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- United-Guardian Reports 2025 Financial Results
- United-Guardian Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- United-Guardian Declares Cash Dividend